Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

COVID cases in Asia surpass 100 million - Reuters tally

Published 03/30/2022, 02:24 AM
Updated 03/30/2022, 02:36 AM
© Reuters. FILE PHOTO: People pass food to residents over the barriers of an area under lockdown, amid the coronavirus disease (COVID-19) pandemic, in Shanghai, China March 25, 2022. REUTERS/Aly Song/File Photo

By Rittik Biswas and Roshan Abraham

(Reuters) - Coronavirus infections in Asia passed 100 million on Wednesday, according to a Reuters tally, as the region records a resurgence in cases, dominated by the BA.2 Omicron sub-variant.

The region is reporting over 1 million new COVID-19 cases about every two days, according to a Reuters analysis. With more than half of the world's population, Asia contributes 21% of all reported COVID-19 cases.

The highly contagious but less deadly BA.2 sub-variant of Omicron has pushed the figures to greater highs in recent weeks in countries such as South Korea, China and Vietnam. BA.2 now represents nearly 86% of all sequenced cases, according to the World Health Organization.

South Korea leads the world in the daily average number of new cases reported, accounting for one in every four infections reported globally each day, as per Reuters analysis.

While the number of cases has levelled off since earlier in March, the country is still reporting over 300 deaths on average each day, with authorities ordering crematoriums nationwide to operate longer.

China is trying to tame its worst outbreak since the pandemic began. The rise in COVID cases in Shanghai, fuelled by the BA.2 substrain, has prompted the financial hub to go into lockdown. The city moved into a two-staged lockdown of its 26 million residents on Monday, restricting movement through bridges and highways to contain the spread.

China has reported over 45,000 new cases since the start of this year, a figure higher than it reported in all of 2021. Even though China has inoculated 90% of its population, not enough elderly people have received booster doses, making them susceptible to reinfections.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Though China is sticking to its plan for crushing the outbreak, experts overseas remain sceptical about the efficacy of lockdowns in the face of the highly infectious Omicron variant.

"It is clear from Australia and elsewhere in the world that lockdowns are simply not effective against Omicron – so expect a big wave coming," said Adrian Esterman, an expert in biostatistics at the University of South Australia.

India alone accounts for 43 million COVID cases, more than the total in the next three worst-hit Asian countries of Japan, South Korea and Vietnam.

India has reported fewer than 2,000 cases per day for the past 11 days versus its peak this year in January of over 300,000 cases on average per day.

Earlier in March, Asia passed 1 million COVID-related deaths. There have now been 1,027,586 million COVID-related deaths across the continent.

Vaccines are considered less effective against the BA.2 subvariant compared to its predecessors. Studies have shown Omicron can reinfect people previously diagnosed with different coronavirus variants.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.